| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human selenium binding protein 1 (SELENBP1) from ORIGENE TECHNOLOGIES | TP302108 | 20 ug | ORIGENE TECHNOLOGIES |
| Human selenocysteine lyase (SCLY) from ORIGENE TECHNOLOGIES | TP720552 | 10 ug | ORIGENE TECHNOLOGIES |
| Human selenocysteine lyase (SCLY) from ORIGENE TECHNOLOGIES | TP303164 | 20 ug | ORIGENE TECHNOLOGIES |
| Human selenophosphate synthetase 2 (SEPHS2) from ORIGENE TECHNOLOGIES | TP301830 | 20 ug | ORIGENE TECHNOLOGIES |
| Human selenophosphate synthetase 1 (SEPHS1) from ORIGENE TECHNOLOGIES | TP309406 | 20 ug | ORIGENE TECHNOLOGIES |
| Human selenoprotein I (SELI) from ORIGENE TECHNOLOGIES | TP720254 | 10 ug | ORIGENE TECHNOLOGIES |
| Human selenophosphate synthetase 1 (SEPHS1), transcript variant 3, full length from ORIGENE TECHNOLOGIES | TP760692 | 50 ug | ORIGENE TECHNOLOGIES |
| SPARC - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN409964 | 1 kit | ORIGENE TECHNOLOGIES |
| Sparc - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN516536 | 1 kit | ORIGENE TECHNOLOGIES |
| SPARC-like 1 (hevin) (SPARCL1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY426947 | 100 ug | ORIGENE TECHNOLOGIES |
| SPARC-like 1 (hevin) (SPARCL1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY417809 | 100 ug | ORIGENE TECHNOLOGIES |
| Sparcl1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN516537 | 1 kit | ORIGENE TECHNOLOGIES |
| SPARCL1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH326078 | 10 ug | ORIGENE TECHNOLOGIES |
| SPARCL1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH307583 | 10 ug | ORIGENE TECHNOLOGIES |
| SPARCL1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN407583 | 1 kit | ORIGENE TECHNOLOGIES |
| SPARC Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH309964 | 10 ug | ORIGENE TECHNOLOGIES |
| Transmembrane protein 60 (TMEM60) from ORIGENE TECHNOLOGIES | LY409878 | 100 ug | ORIGENE TECHNOLOGIES |
| Transmembrane protein 61 (TMEM61) from ORIGENE TECHNOLOGIES | LY405509 | 100 ug | ORIGENE TECHNOLOGIES |
| Transmembrane protein 65 (TMEM65) from ORIGENE TECHNOLOGIES | LY405125 | 100 ug | ORIGENE TECHNOLOGIES |
| Transmembrane protein 66 (TMEM66) from ORIGENE TECHNOLOGIES | LY414173 | 100 ug | ORIGENE TECHNOLOGIES |
| Transmembrane protein 62 (TMEM62) from ORIGENE TECHNOLOGIES | LY410955 | 100 ug | ORIGENE TECHNOLOGIES |
| Transmembrane protein 69 (TMEM69) from ORIGENE TECHNOLOGIES | LY413928 | 100 ug | ORIGENE TECHNOLOGIES |
| Transmembrane protein 74 (TMEM74) from ORIGENE TECHNOLOGIES | LY407196 | 100 ug | ORIGENE TECHNOLOGIES |
| Transmembrane protein 72 (TMEM72) from ORIGENE TECHNOLOGIES | LY426613 | 100 ug | ORIGENE TECHNOLOGIES |
| Transmembrane protein 81 (TMEM81) from ORIGENE TECHNOLOGIES | LY404318 | 100 ug | ORIGENE TECHNOLOGIES |
| Transmembrane protein 85 (TMEM85) from ORIGENE TECHNOLOGIES | LY413961 | 100 ug | ORIGENE TECHNOLOGIES |
| Transmembrane protein 82 (TMEM82) from ORIGENE TECHNOLOGIES | LY422998 | 100 ug | ORIGENE TECHNOLOGIES |
| Transmembrane protein 9 (TMEM9) from ORIGENE TECHNOLOGIES | LY413962 | 100 ug | ORIGENE TECHNOLOGIES |
| Transmembrane protein 88 (TMEM88) from ORIGENE TECHNOLOGIES | LY404348 | 100 ug | ORIGENE TECHNOLOGIES |
| Transmembrane protein 97 (TMEM97) from ORIGENE TECHNOLOGIES | LY415192 | 100 ug | ORIGENE TECHNOLOGIES |
| Transmembrane protein 173 (TMEM173), nuclear gene encoding mitochondrial protein from ORIGENE TECHNOLOGIES | LY405006 | 100 ug | ORIGENE TECHNOLOGIES |
| FEV - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN402917 | 1 kit | ORIGENE TECHNOLOGIES |
| Fev - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN505903 | 1 kit | ORIGENE TECHNOLOGIES |
| FEV Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH302917 | 10 ug | ORIGENE TECHNOLOGIES |
| Spastic paraplegia 21 (autosomal recessive, Mast syndrome) (SPG21), transcript variant 1 from ORIGENE TECHNOLOGIES | LY413881 | 100 ug | ORIGENE TECHNOLOGIES |
| Spastic paraplegia 21 (autosomal recessive, Mast syndrome) (SPG21), transcript variant 3 from ORIGENE TECHNOLOGIES | LY426877 | 100 ug | ORIGENE TECHNOLOGIES |
| Spastic paraplegia 21 (autosomal recessive, Mast syndrome) (SPG21), transcript variant 2 from ORIGENE TECHNOLOGIES | LY426876 | 100 ug | ORIGENE TECHNOLOGIES |
| Spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 1 from ORIGENE TECHNOLOGIES | LY402406 | 100 ug | ORIGENE TECHNOLOGIES |
| Spastic paraplegia 7 (pure and complicated autosomal recessive) (SPG7), nuclear gene encoding mitochondrial protein, transcript variant 1 from ORIGENE TECHNOLOGIES | LY401085 | 100 ug | ORIGENE TECHNOLOGIES |
| Spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 2 from ORIGENE TECHNOLOGIES | LY428019 | 100 ug | ORIGENE TECHNOLOGIES |
| Spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 4 from ORIGENE TECHNOLOGIES | LY428017 | 100 ug | ORIGENE TECHNOLOGIES |
| Spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 3 from ORIGENE TECHNOLOGIES | LY428018 | 100 ug | ORIGENE TECHNOLOGIES |
| Spastin (SPAST), transcript variant 2 from ORIGENE TECHNOLOGIES | LY404560 | 100 ug | ORIGENE TECHNOLOGIES |
| SPAST Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH320458 | 10 ug | ORIGENE TECHNOLOGIES |
| Spast - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN516538 | 1 kit | ORIGENE TECHNOLOGIES |
| SPAST Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH314100 | 10 ug | ORIGENE TECHNOLOGIES |
| SPAST - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN414100 | 1 kit | ORIGENE TECHNOLOGIES |
| SPATA31A7 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN406917 | 1 kit | ORIGENE TECHNOLOGIES |
| SPATA31A1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN413700 | 1 kit | ORIGENE TECHNOLOGIES |
| SPATA31A3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN417331 | 1 kit | ORIGENE TECHNOLOGIES |